A randomized, multicenter, placebo-controlled clinical trial of racotumomab-alum vaccine as switch maintenance therapy in advanced non–small cell lung cancer …

S Alfonso, A Valdés-Zayas, ER Santiesteban… - Clinical Cancer …, 2014 - AACR
Purpose: Racotumomab-alum is an anti-idiotype vaccine targeting the NeuGcGM3 tumor-
associated ganglioside. This clinical trial was conducted to provide a preliminary estimate of …
被引用次数：137 相关文章

A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung …

S Alfonso, A Valdés-Zayas, ER Santiesteban… - Clinical Cancer …, 2014 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Purpose: Racotumomab-alum is an anti-
idiotype vaccine targeting the NeuGcGM3 tumor-associated ganglioside. This clinical trial …
[PDF] archive.org

[PDF][PDF] A randomized, multicenter, placebo-controlled clinical trial of racotumomab-alum vaccine as switch maintenance therapy in advanced non-small-cell-lung …

S Alfonso, A Valdés-Zayas, ER Santiesteban, YI Flores… - scholar.archive.org
Purpose: Racotumomab is an anti-idiotype vaccine targeting the NeuGcGM3 tumor-
associated ganglioside. This clinical trial was conducted to provide a preliminary estimate of …

A randomized, multicenter, placebo-controlled clinical trial of racotumomab-alum vaccine as switch maintenance therapy in advanced non-small cell lung cancer …

S Alfonso, A Valdés-Zayas… - … : an official journal …, 2014 - pubmed.ncbi.nlm.nih.gov
Purpose Racotumomab-alum is an anti-idiotype vaccine targeting the NeuGcGM3 tumor-
associated ganglioside. This clinical trial was conducted to provide a preliminary estimate of …
[PDF] academia.edu

[PDF][PDF] A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell …

S Alfonso, A Valdés-Zayas, ER Santiesteban… - Clin Cancer …, 2014 - academia.edu
Purpose: Racotumomab-alum is an anti-idiotype vaccine targeting the NeuGcGM3 tumor-
associated ganglioside. This clinical trial was conducted to provide a preliminary estimate of …

A randomized, multicenter, placebo-controlled clinical trial of racotumomab-alum vaccine as switch maintenance therapy in advanced non-small cell lung cancer …

S Alfonso, A Valdés-Zayas… - … Cancer Research: an …, 2014 - europepmc.org
Purpose Racotumomab-alum is an anti-idiotype vaccine targeting the NeuGcGM3 tumor-
associated ganglioside. This clinical trial was conducted to provide a preliminary estimate of …

[引用][C] A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non-Small Cell …

S ALFONSO, A VALDES-ZAYAS… - Clinical cancer …, 2014 - pascal-francis.inist.fr
A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine
as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients CNRS …
[PDF] academia.edu

[PDF][PDF] A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell …

S Alfonso, A Valdés-Zayas, ER Santiesteban… - Clin Cancer …, 2014 - academia.edu
Purpose: Racotumomab-alum is an anti-idiotype vaccine targeting the NeuGcGM3 tumor-
associated ganglioside. This clinical trial was conducted to provide a preliminary estimate of …